<DOC>
	<DOCNO>NCT02951897</DOCNO>
	<brief_summary>In 2015-2016 , 224,390 case newly diagnose lung cancer USA . Of case , 83 % non-small cell lung cancer ( NSCLC ) . Currently , 5-year survival rate NSCLC patient 21 % , 25 % early stage NSCLC patient , undergone surgical treatment , relapse progression . Circulating tumor cell ( CTCs ) , shed primary tumor vasculature lymphatics , regard new prognostic factor metastatic process . Thus far , CTCs-detection technology divide epithelial cell adhesion molecule ( EpCAM ) -based detection method , e.g. , widely use CellSearch速 Adnatest速 , EpCAM-independent detection method , e.g. , ISET速 ScreenCell速 . Herein , investigator use newly establish approach , i.e. , CanPatrolTM detect CTCs early stage lung Adenocarcinoma case . The investigator aim explore whether CTCs detection prior surgery contributive early diagnosis , may help predict prognosis guide treatment strategy early stage lung Adenocarcinoma .</brief_summary>
	<brief_title>Application Detecting Circulating Tumor Cells Accurate Treatment Early Stage Lung Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>stage I lung adenocarcinoma case new adjuvant treatment prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>circulate tumor cell</keyword>
	<keyword>lung adenocarcinoma</keyword>
	<keyword>treatment</keyword>
	<keyword>early diagnosis</keyword>
</DOC>